Valuing biopharmaceutical alliances : decisions for new product development in the pharmaceutical industry : the effects of corporate downsizing on women

Thesis (Ph.D.)--Massachusetts Institute of Technology, Dept. of Economics, 1998. === Includes bibliographical references (p. 166-174). === This thesis presents two empirical essays, which examine the organization of research and development in the pharmaceutical industry and a third essay that exami...

Full description

Bibliographic Details
Main Author: Rodriguez, Daniel, 1965-
Other Authors: Nancy L. Rose and Gelnn Ellison.
Format: Others
Language:English
Published: Massachusetts Institute of Technology 2005
Subjects:
Online Access:http://hdl.handle.net/1721.1/9645
id ndltd-MIT-oai-dspace.mit.edu-1721.1-9645
record_format oai_dc
spelling ndltd-MIT-oai-dspace.mit.edu-1721.1-96452020-07-15T07:09:31Z Valuing biopharmaceutical alliances : decisions for new product development in the pharmaceutical industry : the effects of corporate downsizing on women Rodriguez, Daniel, 1965- Nancy L. Rose and Gelnn Ellison. Massachusetts Institute of Technology. Department of Economics Economics Thesis (Ph.D.)--Massachusetts Institute of Technology, Dept. of Economics, 1998. Includes bibliographical references (p. 166-174). This thesis presents two empirical essays, which examine the organization of research and development in the pharmaceutical industry and a third essay that examines the effects of corporate downsizing on the growing number of women in the labor force. Chapter 2 begins by evaluating strategic alliances undertaken in the pharmaceutical industry. The analysis estimates equity market reaction to the announcements of these partnerships and determines how partner and transaction characteristics affect this reaction. The results indicate that these partnerships have created significant shareholder value. Additionally, there is significant heterogeneity across alliances. Equity participation is correlated with a higher level of value creation. Alliances undertaken for the purposes of developing or marketing products that target complex diseases create less shareholder value. Finally, R&D firms that have been previously performing well do not gain as much as their more poorly performing counterparts. Chapter 3 examines the organization of new product development. Using a unique dataset of approved drug products, the empirical analyses include firm characteristics and new drug characteristics in limited dependent variable estimation of the firm decision over how to organize its R&D. The results show that a firm's research expertise as measured by patent stock is correlated with less integrated development, and that a firm's development expertise as measured by previously approved drugs, is correlated with integrated development. Additionally, firms with new products designed for complex diseases bring them to market through in-house resources. The final chapter employs a comprehensive dataset on downsized and non­downsized workers to complete a series of estimations that show a convergence in the downsizing experiences of men and women in the probability of displacement and wage loss due to downsizing. In addition to this convergence, the analysis finds that the experiences of men and women have maintained persistent dissimilarities. Specifically, the probability of leaving the labor force, of finding part-time reemployment, and the duration of unemployment following displacement continues to be significantly higher for downsized women. Finally, the probability of reemployment is significantly lower for downsized women. Interestingly, marital status accounts for a significant proportion of these findings. by Daniel Rodriguez. Ph.D. 2005-08-19T19:09:50Z 2005-08-19T19:09:50Z 1998 1998 Thesis http://hdl.handle.net/1721.1/9645 42379017 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 174 p. 14316800 bytes 14316556 bytes application/pdf application/pdf application/pdf Massachusetts Institute of Technology
collection NDLTD
language English
format Others
sources NDLTD
topic Economics
spellingShingle Economics
Rodriguez, Daniel, 1965-
Valuing biopharmaceutical alliances : decisions for new product development in the pharmaceutical industry : the effects of corporate downsizing on women
description Thesis (Ph.D.)--Massachusetts Institute of Technology, Dept. of Economics, 1998. === Includes bibliographical references (p. 166-174). === This thesis presents two empirical essays, which examine the organization of research and development in the pharmaceutical industry and a third essay that examines the effects of corporate downsizing on the growing number of women in the labor force. Chapter 2 begins by evaluating strategic alliances undertaken in the pharmaceutical industry. The analysis estimates equity market reaction to the announcements of these partnerships and determines how partner and transaction characteristics affect this reaction. The results indicate that these partnerships have created significant shareholder value. Additionally, there is significant heterogeneity across alliances. Equity participation is correlated with a higher level of value creation. Alliances undertaken for the purposes of developing or marketing products that target complex diseases create less shareholder value. Finally, R&D firms that have been previously performing well do not gain as much as their more poorly performing counterparts. Chapter 3 examines the organization of new product development. Using a unique dataset of approved drug products, the empirical analyses include firm characteristics and new drug characteristics in limited dependent variable estimation of the firm decision over how to organize its R&D. The results show that a firm's research expertise as measured by patent stock is correlated with less integrated development, and that a firm's development expertise as measured by previously approved drugs, is correlated with integrated development. Additionally, firms with new products designed for complex diseases bring them to market through in-house resources. The final chapter employs a comprehensive dataset on downsized and non­downsized workers to complete a series of estimations that show a convergence in the downsizing experiences of men and women in the probability of displacement and wage loss due to downsizing. In addition to this convergence, the analysis finds that the experiences of men and women have maintained persistent dissimilarities. Specifically, the probability of leaving the labor force, of finding part-time reemployment, and the duration of unemployment following displacement continues to be significantly higher for downsized women. Finally, the probability of reemployment is significantly lower for downsized women. Interestingly, marital status accounts for a significant proportion of these findings. === by Daniel Rodriguez. === Ph.D.
author2 Nancy L. Rose and Gelnn Ellison.
author_facet Nancy L. Rose and Gelnn Ellison.
Rodriguez, Daniel, 1965-
author Rodriguez, Daniel, 1965-
author_sort Rodriguez, Daniel, 1965-
title Valuing biopharmaceutical alliances : decisions for new product development in the pharmaceutical industry : the effects of corporate downsizing on women
title_short Valuing biopharmaceutical alliances : decisions for new product development in the pharmaceutical industry : the effects of corporate downsizing on women
title_full Valuing biopharmaceutical alliances : decisions for new product development in the pharmaceutical industry : the effects of corporate downsizing on women
title_fullStr Valuing biopharmaceutical alliances : decisions for new product development in the pharmaceutical industry : the effects of corporate downsizing on women
title_full_unstemmed Valuing biopharmaceutical alliances : decisions for new product development in the pharmaceutical industry : the effects of corporate downsizing on women
title_sort valuing biopharmaceutical alliances : decisions for new product development in the pharmaceutical industry : the effects of corporate downsizing on women
publisher Massachusetts Institute of Technology
publishDate 2005
url http://hdl.handle.net/1721.1/9645
work_keys_str_mv AT rodriguezdaniel1965 valuingbiopharmaceuticalalliancesdecisionsfornewproductdevelopmentinthepharmaceuticalindustrytheeffectsofcorporatedownsizingonwomen
_version_ 1719326097975279616